TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer
Xin Nie,1,2 Cong Liu,3 Qian Guo,1,2 Ming-jun Zheng,1,2 Ling-ling Gao,1,2 Xiao Li,1,2 Da-wo Liu,1,2 Lian-cheng Zhu,1,2 Juan-juan Liu,1,2 Bei Lin1,2 1Department of Obstetrics and Gynaecology, Shengjing Hospital Affiliated to China Medical University, Liaoning, China; 2Key Laboratory of Maternal-Fetal...
Main Authors: | Nie X, Liu C, Guo Q, Zheng M, Gao L, Li X, Liu D, Zhu L, Liu J, Lin B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/tmeff1-overexpression-and-its-mechanism-for-tumor-promotion-in-ovarian-peer-reviewed-article-CMAR |
Similar Items
-
Butorphanol Inhibits the Malignant Biological Behaviors of Ovarian Cancer Cells via Down-Regulating the Expression of TMEFF1
by: Wang B, et al.
Published: (2020-10-01) -
TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway
by: Han H, et al.
Published: (2019-12-01) -
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
by: Sidi Xie, et al.
Published: (2021-03-01) -
Long non-coding RNA LINC01963 inhibits progression of pancreatic carcinoma by targeting miR-641/TMEFF2
by: Kailiang Li, et al.
Published: (2020-09-01) -
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer
by: Constantin Georgescu, et al.
Published: (2019-05-01)